MDL 101,731

Definition / meaning of MDL 101,731

A drug that belongs to a family of drugs called ribonucleotide reductase inhibitors.

Listed under:

Find More About 'MDL 101,731'

Source(s):

The Web site of the National Cancer Institute (http://www.cancer.gov/)

Leave a Comment

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.